By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Rosetta Genomics Ltd. 

10 Plaut Street

Rehovot    76706  Israel
Phone: 972-0-8-9484755 Fax: 972-0-8-9484766



Company News
Rosetta Genomics (ROSG) Fortifies Patent Protection For Its Unique RosettaGX Reveal Assay 3/20/2017 7:17:06 AM
Rosetta Genomics (ROSG) Announces 1-for-12 Reverse Stock Split 3/16/2017 10:52:20 AM
Rosetta Genomics (ROSG) Reports Preliminary RosettaGX Reveal Financial Results For The 2016 Fourth Quarter And Year 2/8/2017 9:19:31 AM
Rosetta Genomics (ROSG) Announces Key U.S. Patent Allowances For Two RosettaGx Reveal microRNAs 2/6/2017 7:47:14 AM
Rosetta Genomics (ROSG) Release: Aegis Restates "Buy" Rating On Shares Of Rosetta Genomics 1/12/2017 9:11:58 AM
Rosetta Genomics (ROSG) Enters Research Collaboration Using Microrna Biomarkers To Predict Response To Leading Immuno-Oncology Drug Nivolumab In Lung Cancer Patients 11/21/2016 11:08:41 AM
Rosetta Genomics (ROSG) Release: Clinical Validation Study For RosettaGX Reveal Published In The Journal Of Clinical Pathology 10/27/2016 11:00:53 AM
Toft Group Completes Chief Commercial Officer Search For Rosetta Genomics (ROSG) In Princeton, NJ 10/27/2016 10:04:55 AM
Rosetta Genomics (ROSG) Release: RosettaGX Reveal Analytical Validation Study Featured On The Cover Of The October Issue Of Cancer Cytopathology 10/24/2016 11:10:56 AM
Rosetta Genomics (ROSG) Appoints Mark R. Willig As Chief Commercial Officer 10/20/2016 11:08:36 AM